- Home
- LIVN vs GENI Comparison
LIVN vs GENI Comparison
Compare LIVN & GENI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIVN
- GENI
- Stock Information
- Founded
- LIVN 1987
- GENI 2016
- Country
- LIVN United Kingdom
- GENI United Kingdom
- Employees
- LIVN N/A
- GENI N/A
- Industry
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- GENI Services-Misc. Amusement & Recreation
- Sector
- LIVN Health Care
- GENI Consumer Discretionary
- Exchange
- LIVN Nasdaq
- GENI Nasdaq
- Market Cap
- LIVN 2.2B
- GENI 2.1B
- IPO Year
- LIVN 1993
- GENI N/A
- Fundamental
- Price
- LIVN $35.58
- GENI $10.33
- Analyst Decision
- LIVN Buy
- GENI Strong Buy
- Analyst Count
- LIVN 7
- GENI 12
- Target Price
- LIVN $60.29
- GENI $11.79
- AVG Volume (30 Days)
- LIVN 772.6K
- GENI 3.7M
- Earning Date
- LIVN 05-07-2025
- GENI 05-07-2025
- Dividend Yield
- LIVN N/A
- GENI N/A
- EPS Growth
- LIVN 262.50
- GENI N/A
- EPS
- LIVN 1.16
- GENI N/A
- Revenue
- LIVN $1,253,437,000.00
- GENI $510,894,000.00
- Revenue This Year
- LIVN $5.79
- GENI $23.33
- Revenue Next Year
- LIVN $5.35
- GENI $16.38
- P/E Ratio
- LIVN $30.67
- GENI N/A
- Revenue Growth
- LIVN 8.66
- GENI 23.71
- 52 Week Low
- LIVN $32.48
- GENI $4.91
- 52 Week High
- LIVN $64.48
- GENI $11.16
- Technical
- Relative Strength Index (RSI)
- LIVN 40.50
- GENI 57.82
- Support Level
- LIVN $32.65
- GENI $9.12
- Resistance Level
- LIVN $35.89
- GENI $9.85
- Average True Range (ATR)
- LIVN 1.91
- GENI 0.63
- MACD
- LIVN 0.05
- GENI 0.05
- Stochastic Oscillator
- LIVN 42.70
- GENI 95.82
About LIVN LivaNova PLC
UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
About GENI Genius Sports Limited
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.